DE69133214D1 - Medikamente zur topischen anwendung von sexualhormonen zur behandlung des trockenen auges, und verfahren zu ihrer herstellung und anwendung - Google Patents

Medikamente zur topischen anwendung von sexualhormonen zur behandlung des trockenen auges, und verfahren zu ihrer herstellung und anwendung

Info

Publication number
DE69133214D1
DE69133214D1 DE69133214T DE69133214T DE69133214D1 DE 69133214 D1 DE69133214 D1 DE 69133214D1 DE 69133214 T DE69133214 T DE 69133214T DE 69133214 T DE69133214 T DE 69133214T DE 69133214 D1 DE69133214 D1 DE 69133214D1
Authority
DE
Germany
Prior art keywords
dry eye
medicines
treating
production
vehicle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69133214T
Other languages
English (en)
Other versions
DE69133214T2 (de
Inventor
Virginia Lubkin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69133214D1 publication Critical patent/DE69133214D1/de
Publication of DE69133214T2 publication Critical patent/DE69133214T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69133214T 1991-08-17 1991-08-17 Medikamente zur topischen anwendung von sexualhormonen zur behandlung des trockenen auges, und verfahren zu ihrer herstellung und anwendung Expired - Fee Related DE69133214T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1991/005863 WO1993003731A1 (en) 1991-08-17 1991-08-17 Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application

Publications (2)

Publication Number Publication Date
DE69133214D1 true DE69133214D1 (de) 2003-04-17
DE69133214T2 DE69133214T2 (de) 2003-12-18

Family

ID=22225745

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69133214T Expired - Fee Related DE69133214T2 (de) 1991-08-17 1991-08-17 Medikamente zur topischen anwendung von sexualhormonen zur behandlung des trockenen auges, und verfahren zu ihrer herstellung und anwendung
DE0652754T Pending DE652754T1 (de) 1991-08-17 1991-08-17 Medikamente zur topischen anwendung von sexualhormonen zur behandlung des trockenen auges, und verfahren zu ihrer herstellung und anwendung.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE0652754T Pending DE652754T1 (de) 1991-08-17 1991-08-17 Medikamente zur topischen anwendung von sexualhormonen zur behandlung des trockenen auges, und verfahren zu ihrer herstellung und anwendung.

Country Status (8)

Country Link
US (1) US5041434A (de)
EP (1) EP0652754B1 (de)
AT (1) ATE234100T1 (de)
DE (2) DE69133214T2 (de)
DK (1) DK0652754T3 (de)
ES (1) ES2086268T3 (de)
GR (1) GR960300027T1 (de)
WO (1) WO1993003731A1 (de)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041434A (en) * 1991-08-17 1991-08-20 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
DE4038128A1 (de) * 1990-11-27 1992-06-04 Schering Ag 8-en-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
US5958912A (en) * 1992-04-21 1999-09-28 The Schepens Eye Research Institute, Inc. Ocular therapy in keratoconjunctivitis sicca using topically applied androgens of TGF-β
US5352445A (en) * 1992-05-07 1994-10-04 Lavaux Joseph E Lavaux tear test lacrimal equilibration time (LET)
US5827245A (en) * 1992-07-16 1998-10-27 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising the active subtance 17-β-Estradiol (Anhydrous)
US5830508A (en) * 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
US5290572A (en) * 1992-08-06 1994-03-01 Deo Corporation Opthalmic composition for treating dry eye
WO1994004155A1 (en) * 1992-08-19 1994-03-03 Health Resource Institute, Ltd. Dehydroepiandrosterone therapy for the treatment of eye disorders
US5639743A (en) * 1992-11-13 1997-06-17 University Of Georgia Research Foundation Compositions and methods for treating exocrine gland atrophy
US5696166A (en) * 1995-10-31 1997-12-09 Yanni; John M. Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
WO1997020578A1 (en) * 1995-12-04 1997-06-12 University Of Miami Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance
AUPO427196A0 (en) * 1996-12-19 1997-01-23 University Of Sydney, The A method for preventing or controlling cataract
ZA989513B (en) 1997-10-21 1999-04-21 Alcon Lab Inc Compositions containing histamine H2 agonists and methods of use in treating dry eye
US6096733A (en) * 1998-12-10 2000-08-01 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
WO2000038663A2 (en) 1998-12-24 2000-07-06 Alcon Laboratories, Inc. Ep4 receptor agonists for treatment of dry eye
AU775189B2 (en) 1999-11-09 2004-07-22 Alcon Inc. Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
WO2001034550A2 (en) 1999-11-09 2001-05-17 Alcon Universal Ltd. 15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders
AU1101301A (en) 1999-11-09 2001-06-06 Alcon Universal Limited 2,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of use
CA2386636A1 (en) 1999-11-09 2001-05-17 Alcon, Inc. 15-hydroxyeicosatetraenoic acid-related compounds and methods of use
ATE265996T1 (de) 1999-11-09 2004-05-15 Alcon Inc Tri-heteroatom-substituierte und zwei kohlenstoff homologe von 15-hete und verfahren zur verwendung
US6803385B2 (en) 1999-11-09 2004-10-12 Alcon, Inc. Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
US6458854B2 (en) 1999-11-09 2002-10-01 Alcon Universal Ltd. Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use
JP2003514782A (ja) 1999-11-09 2003-04-22 アルコン，インコーポレイテッド ドライアイの処置のためのリポキシンａ４およびそのアナログ
PL356092A1 (en) 1999-11-09 2004-06-14 Alcon Inc. Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use
US6552084B2 (en) 1999-11-09 2003-04-22 Alcon Universal Ltd. Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
WO2001034549A1 (en) 1999-11-09 2001-05-17 Alcon Universal Ltd. Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders
DE60007548T2 (de) 1999-11-09 2004-06-17 Alcon, Inc. Omega kettenmodifizierte hydroxyeicosatetraensäure derivate verwendbar in der behandlung der "trockenes auge" krankheit
AU1226001A (en) 1999-11-09 2001-06-06 Alcon Universal Limited Phospholipids of hydroxyeicosatetraenoic acid-like derivatives
PT1228030E (pt) 1999-11-09 2005-08-31 Alcon Inc Derivados benzenoidicos do acido 15-hidroxieicosatetraenoico e metodos para a sua utilizacao no tratamento das perturbacoes do olho seco
WO2001046134A1 (en) 1999-12-22 2001-06-28 Alcon Universal Ltd. 6-KETO PROSTAGLANDIN F1α AND ANALOGS FOR TREATING DRY EYE
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
CA2426885C (en) * 2000-11-14 2010-06-29 Vital Health Sciences Pty Ltd Complexes of phosphate derivatives
MXPA03010634A (es) 2001-05-21 2004-03-09 Alcon Inc Uso de inhibidores de proteasoma para tratar trastornos del ojo seco.
CA2447883A1 (en) 2001-05-21 2002-11-28 Alcon, Inc. Use of nf-kappa-b inhibitors to treat dry eye disorders
EP1392322A1 (de) * 2001-05-21 2004-03-03 Alcon, Inc. Methode zur behandlung des trockenen auges
US6872382B1 (en) 2001-05-21 2005-03-29 Alcon, Inc. Use of selective PDE IV inhibitors to treat dry eye disorders
US7112588B2 (en) * 2001-05-21 2006-09-26 Alcon, Inc. Use of proteasome inhibitors to treat dry eye disorders
US6645994B1 (en) 2001-06-01 2003-11-11 Alcon, Inc. Method of treating dry eye disorders
US6750250B1 (en) 2001-07-12 2004-06-15 Alcon, Inc. 11,12-oxidoarachidonic acid derivatives and methods of their use in treating dry eye disorders
CN1547475B (zh) * 2001-07-27 2010-12-15 生命健康科学有限公司 含电子转移试剂的磷酸酯衍生物的皮肤制剂
WO2003028667A2 (en) * 2001-10-04 2003-04-10 Cellegy Pharmaceuticals, Inc. Semisolid topical hormonal compositions and methods for treatment
WO2003030892A1 (en) * 2001-10-11 2003-04-17 Alcon, Inc. Methods for treating dry eye
WO2003030894A1 (en) * 2001-10-11 2003-04-17 Alcon, Inc. Methods for treating dry eye
US20030109509A1 (en) * 2001-10-11 2003-06-12 Alcon, Inc. Methods for treating dry eye
EP1460995B1 (de) * 2001-12-13 2010-11-10 Vital Health Sciences Pty Ltd. Transdermaler transport von verbindungen
US6659985B2 (en) 2002-01-30 2003-12-09 Southern College Of Optometry Method to use transdermal administration of androgens to the adnexa of the eye
US20070213310A1 (en) * 2002-04-01 2007-09-13 Laszlo Prokai Prodrugs for Use as Ophthalmic Agents
US7186707B2 (en) * 2002-04-01 2007-03-06 University Of Florida Prodrugs for use as ophthalmic agents
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
MXPA05003063A (es) * 2002-09-20 2005-05-27 Alcon Inc Uso de inhibidores de la sintesis de citosina para el tratamiento de trastornos de ojos secos.
AU2003290776A1 (en) * 2002-11-15 2004-06-15 Panaseca, Inc. Methods and compositions for alleviating dry eyes
WO2004069248A1 (en) * 2002-12-09 2004-08-19 University Of Florida Prodrugs for use a ophthalmic agents
US20040248794A1 (en) * 2002-12-20 2004-12-09 Yanni John M. Treatment of dry eye by restoring 15-lipoxygenase activity to ocular surface cells
ATE534384T1 (de) * 2003-01-17 2011-12-15 Vital Health Sciences Pty Ltd Verbindungen mit proliferationshemmenden eigenschaften
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
US7235556B2 (en) * 2003-04-16 2007-06-26 Alcon, Inc. Methods of treating dry eye disorders
US20060281716A1 (en) 2004-03-03 2006-12-14 West Simon M Alkaloid formulations
CA2562356A1 (en) 2004-04-08 2005-10-27 Retmed Pty Ltd Treatment of ophthalmic conditions with mineralcorticoids
PL1744736T3 (pl) * 2004-05-14 2010-03-31 Alcon Inc Sposób leczenia zespołu suchego oka i zapalenia błony naczyniowej oka
US7923471B2 (en) * 2004-05-14 2011-04-12 Alcon, Inc. Method of treating dry eye disorders and uveitis
US7223737B1 (en) 2004-08-13 2007-05-29 Alcon, Inc. Method of treating dry eye disorders using glycosides
US20060128803A1 (en) * 2004-12-14 2006-06-15 Alcon, Inc. Method of treating dry eye disorders using 13(S)-HODE and its analogs
US9161905B2 (en) * 2005-01-12 2015-10-20 Ocular Research Of Boston, Inc. Dry eye treatment
EP1858523A1 (de) * 2005-03-02 2007-11-28 Nascent Pharmaceutical, Inc. Kombinationstherapie zur topischen applikation bei der behandlung von trockenen augen
JP2008531602A (ja) * 2005-03-03 2008-08-14 バイタル ヘルス サイエンシズ プロプライアタリー リミティド 抗癌特性を有する化合物
WO2006132033A1 (ja) 2005-06-10 2006-12-14 Pola Chemical Industries Inc. 新規トリテルペン酸誘導体及びそれを含有してなる皮膚外用剤
NZ565049A (en) * 2005-06-17 2012-02-24 Vital Health Sciences Pty Ltd A carrier comprising one or more DI and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
CA2631653A1 (en) * 2005-12-23 2007-06-28 Vital Health Sciences Pty Ltd. Compounds having cytokine modulating properties
US7745461B1 (en) 2006-02-27 2010-06-29 Alcon Research, Ltd. Method of treating dry eye disorders
PL2374472T3 (pl) 2006-03-16 2018-11-30 Dyax Corp. Kompozycje i sposoby leczenia zaburzeń okulistycznych
US20080132475A1 (en) * 2006-12-05 2008-06-05 Charles Gerald Connor Treatment for dry eye
US20080221070A1 (en) * 2007-03-06 2008-09-11 Pierce William M Methods and compounds for the targeted delivery of agents to bone for interaction therewith
EP2129373B1 (de) * 2007-04-02 2013-05-22 DSM IP Assets B.V. Verwendung von Genistein zur Behandlung von trockenem Auge
NZ582188A (en) * 2007-07-11 2012-03-30 Pfizer Pharmaceutical compositions and methods of treating dry eye disorders
US20090098136A1 (en) * 2007-10-15 2009-04-16 Alcon Research, Ltd. Use of tnf receptor antagonists for treating dry eye
TW200927192A (en) * 2007-11-19 2009-07-01 Alcon Res Ltd Use of TRPV1 receptor antagonists for treating dry eye and ocular pain
US20100016264A1 (en) * 2007-12-05 2010-01-21 Connor Charles G Treatment for dry eye using testosterone and progestagen
US8207226B1 (en) 2008-06-03 2012-06-26 Alcon Research, Ltd. Use of FAAH antagonists for treating dry eye and ocular pain
CN102317288A (zh) 2009-02-13 2012-01-11 佛维雅制药公司 作为激酶抑制剂的[1,2,4]三唑并[1,5-a]吡啶
EP2496233A1 (de) * 2009-11-06 2012-09-12 Alcon Research, Ltd. Nahrungsergänzungen zur linderung von trockenem auge
US10071030B2 (en) 2010-02-05 2018-09-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
CA2794734C (en) 2010-03-30 2017-12-12 Phosphagenics Limited Transdermal delivery patch
AR081960A1 (es) 2010-06-22 2012-10-31 Fovea Pharmaceuticals Sa Compuestos heterociclicos, su preparacion y su aplicacion terapeutica
US20120079612A1 (en) * 2010-09-24 2012-03-29 West Virginia University Dry eye animal model
EP2685992A4 (de) 2011-03-15 2014-09-10 Phosphagenics Ltd Aminochinoline als kinasehemmer
CN110812486A (zh) * 2012-07-09 2020-02-21 华柏恩视觉研究中心 用于预防和/或治疗干眼症的组合物、方法和/或装置
US10507245B2 (en) * 2012-07-19 2019-12-17 Luis Felipe Vejarano Restrepo Ophthalmic formulation and method for ameliorating presbyopia
EP3021857B1 (de) * 2013-07-19 2018-03-21 The Johns Hopkins University Biomaterialien mit hyaluronsäurebindenden peptiden und extrazellulären matrixbindenden peptiden für hyaluronsäureretention und gewebezüchtungsanwendungen
CN114712308A (zh) 2015-12-09 2022-07-08 磷肌酸有限公司 药物制剂
CA3032790A1 (en) 2016-06-20 2017-12-28 Novartis Ag Methods of treating dry eye disease using tnf.alpha. antagonists
AU2017381395A1 (en) 2016-12-21 2019-06-20 Phosphagenics Limited Process
US10843325B2 (en) 2017-03-08 2020-11-24 DePuy Synthes Products, Inc. Quick coupling apparatus on instrument handle

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2861920A (en) * 1954-05-04 1958-11-25 Upjohn Co Therapeutic suspensions of steroids containing pvp and/or pva
US3299104A (en) * 1963-04-09 1967-01-17 Leo Ab Certain steroid nu-bis-(haloethyl)-carbamates
US3962430A (en) * 1974-08-07 1976-06-08 Merck & Co., Inc. Sterilization of solid non-electrolyte medicinal agents employing sodium chloride
US4154820A (en) * 1976-02-23 1979-05-15 Akzona Incorporated Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
US4082881A (en) * 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier
HU181703B (en) * 1980-05-09 1983-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents
JPS58126810A (ja) * 1981-12-24 1983-07-28 Kaken Pharmaceut Co Ltd 抗炎症眼科用液剤およびその製法
US4478818A (en) * 1982-12-27 1984-10-23 Alza Corporation Ocular preparation housing steroid in two different therapeutic forms
US4581226A (en) * 1983-04-07 1986-04-08 Dillon Richard S Method of treating sensitive animal tissue with a specially processed seawater solution
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
SE8305864D0 (sv) * 1983-10-25 1983-10-25 L E Medical Ogondroppar
US4617299A (en) * 1983-12-19 1986-10-14 Knepper Paul A Method for the prevention of ocular hypertension, treatment of glaucoma and treatment of ocular hypertension
US4812448A (en) * 1984-10-22 1989-03-14 Knepper Paul A Method for the prevention of ocular hypertension, treatment of glaucoma and treatment of ocular hypertension
US4863912A (en) * 1986-05-19 1989-09-05 New York Medical College Use of tetrahydrocortisol in glaucoma therapy
US4774236A (en) * 1986-09-17 1988-09-27 Research Triangle Institute 17α-(substituted-methyl)-17β-hydroxy/esterified hydroxy steroids and pharmaceutical compositions containing them
US4861763A (en) * 1986-09-17 1989-08-29 Research Triangle Institute 17 α-(substituted-methyl)-17β-hydroxy/esterified hydroxy steroids and their progestational use
US4866049A (en) * 1987-08-10 1989-09-12 Spectra Pharmaceutical Services, Inc. Ophthalmic compositionn and method of using same
US4954490A (en) * 1988-06-23 1990-09-04 Research Triangle Institute 11 β-substituted progesterone analogs
US4951683A (en) * 1989-01-19 1990-08-28 Davis Jeffrey P Device for detecting keratoconjunctivitis sicca
US5041434A (en) * 1991-08-17 1991-08-20 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application

Also Published As

Publication number Publication date
ATE234100T1 (de) 2003-03-15
GR960300027T1 (en) 1996-05-31
EP0652754A4 (de) 1994-11-09
EP0652754B1 (de) 2003-03-12
EP0652754A1 (de) 1995-05-17
DK0652754T3 (da) 2003-06-10
ES2086268T1 (es) 1996-07-01
DE69133214T2 (de) 2003-12-18
ES2086268T3 (es) 2003-11-16
WO1993003731A1 (en) 1993-03-04
US5041434A (en) 1991-08-20
DE652754T1 (de) 1996-09-12

Similar Documents

Publication Publication Date Title
DE69133214D1 (de) Medikamente zur topischen anwendung von sexualhormonen zur behandlung des trockenen auges, und verfahren zu ihrer herstellung und anwendung
KR870010862A (ko) 비내투여용 수성 스테로이드 제제
ATE214931T1 (de) Antibakterielle präparate für die ohren ohne irritierende, sensibilisierende und ototoxische wirkungen
PT92069A (pt) Processo para a producao de um sistema de distribuicao de drogas
ATE215814T1 (de) Galenische einzeldosierung zur lokalen hormontherapie der vaginalen trockenheit
NO307445B1 (no) Farmasøytiske preparater inneholdende nanokapsler og fremgangsmõte for fremstilling derav
NO20005431D0 (no) Gelérbare farmasøytiske preparater
ES2130622T3 (es) Sistema para la administracion transdermica de farmacos.
HUP9801234A2 (hu) Nitroglicerint tartalmazó, vizes alapú, helyileg alkalmazható krém, eljárás előállítására és alkalmazása
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
CA2392050A1 (en) Pharmaceutical formulations containing zolmitriptan
KR920703041A (ko) 통증을 수반하는 염증성 또는 알레르기성 질환치료에 사용되는 성분물과 그 방법
ATE172117T1 (de) Verwendung von trospiumchlorid zur herstellung eines arzneimittels zur behandlung von blasenkrankheiten
DE69634472D1 (de) Adrenal-Cortikosteroide enthaltende therapeutische Zusammensetzung zur äusserlichen Anwendung für Dermatitis-Behandlung
KR930019224A (ko) 유산 위험 치료제
ES2084348T3 (es) N-((4,5-dihidroxi- y 4,5,8-trihidroxi-9,10-dihidro-9,10-dioxo-2-antracen-il)carbonil)aminoacidos utiles en la terapia de afecciones osteoarticulares.
ES2060440T3 (es) Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos.
ATE179070T1 (de) Dithranol enthaltendes arzneimittel zur topischen anwendung sowie herstellungsverfahren
KR900700115A (ko) 토브라마이신 및 스테로이드 조성물
KR900701263A (ko) 이보파민의 수용성 산 부가 염을 포함하는 안과용 약학 조성물
KR940000462A (ko) 신규의 알카로이드 유도체, 이의 용도 및 이를 함유한 제약적 조성물
UA28093C2 (uk) Жовчогінний та антилітогенний засіб з нативної жовчі свійської птиці та спосіб його одержання
ATE94766T1 (de) Verfahren zur herstellung einer galenischen zubereitung mit optimaler bioverfuegbarkeit des wirkstoffs 2-hydroxy-5-methyllaurophenonoxime (hmlo).
TH6259A (th) สารผสมทางเภสัชกรรมสำหรับใช้ในโพรงจมูก ประกอบด้วยฮอร์โมนกระตุ้นการหลั่งของ gh โคลิเนอร์จิล แอโกนิสท์ และเกลือของน้ำดี
RU94011862A (ru) Способ лечения гемофтальма

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee